Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Oncology
Multiple Myeloma
,
Oncology
Novel Drug Classes Make News in Multiple Myeloma
Caroline Helwick
Read More
Lung Cancer
,
Oncology
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
Wayne Kuznar
Read More
Lung Cancer
,
Oncology
Ramucirumab Shows Survival Benefit in NSCLC
Caroline Helwick
Read More
Leukemia
,
Oncology
Ibrutinib Outperforms Ofatumumab in Patients with Relapsed/Refractory CLL
Caroline Helwick
Read More
Leukemia
,
Oncology
Idelalisib Improves Outcomes in Heavily Pretreated Patients with CLL
Wayne Kuznar
Read More
Multiple Myeloma
,
Oncology
Myeloma Drug Arsenal Expanding to New Classes
Caroline Helwick
Read More
Multiple Myeloma
,
Oncology
Lenalidomide Maintenance in Transplant-Eligible Myeloma Population Still Debated
Caroline Helwick
Read More
Multiple Myeloma
,
Oncology
FIRST Trial Shows Value for Continued Use of Lenalidomide in Transplant-Ineligible Patients with Newly Diagnosed Myeloma
Caroline Helwick
Read More
Leukemia
,
Oncology
Nilotinib Sustains Deeper Molecular Response versus Imatinib in Patients with Ph+ CML
Wayne Kuznar
Read More
Leukemia
,
Oncology
Novel Anti-CD20 Antibodies Show Promising Results in Unfit Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
Read More
18
19
20
21
22
23
24
Page 21 of 27
Results 201 - 210 of 262